US gene patent ruling sends message to Australian policy makers, say Cancer Council, COSA

A US court ruling that patents should never have been granted for the BRCA1 and BRCA2 gene mutations linked to breast and ovarian cancer reinforces Cancer Council Australia and the Clinical Oncological Society of Australia’s (COSA’s) call for gene patenting law reform in Australia.